Mesenchymal stem cells (MSCs) are a type of adult stem cell that play a central role in many regenerative protocols. They can be sourced from several tissues and are studied for their ability to modulate inflammation, support tissue repair, and influence the behavior of nearby cells.

What They Are

MSCs are multipotent cells — meaning they can develop into several different cell types, including bone, cartilage, and fat cells. More importantly for most clinical applications, MSCs are powerful signaling cells. They release growth factors, cytokines, and exosomes that influence how surrounding tissue heals and how the immune system responds.

How MSCs Are Used Clinically

• Orthopedic applications: Joint repair, cartilage support, tendon and ligament recovery
• Inflammatory and autoimmune conditions: Modulating immune response in select clinical situations
• Neurological recovery: Active research area for brain and nerve injury
• Wound healing: Supporting tissue regeneration in chronic or slow-healing wounds

What the Research Shows

MSCs have one of the deepest research bases in regenerative medicine. Hundreds of clinical trials have been conducted across many conditions. The picture that emerges is nuanced:

• Strong evidence for safety across most applications
• Meaningful efficacy in certain orthopedic and inflammatory indications
• Mixed or early-stage evidence for many other applications
• Outcomes depend heavily on cell source, processing, dose, and delivery method

Not every commercially marketed stem cell product is supported by quality research. Sourcing and protocol matter.

How They’re Delivered

Depending on the clinical situation, MSCs may be delivered via direct injection into the target tissue (such as a joint), intravenously, or as part of a combination protocol with other regenerative agents.

Safety Considerations

MSC therapy has a generally favorable safety profile in the regulated settings where it’s appropriately used. As with any procedure, there are risks: standard injection risks, the importance of sterile preparation, and considerations specific to certain patient populations. MSC therapy is generally not appropriate for patients with active cancer or certain immune conditions — your clinician will review your specific situation.

Important Note on Quality and Source

The stem cell space includes both legitimate clinical care and overstated marketing. At Chambers Clinic, MSC protocols use products from regulated sources with documented processing and quality controls. We’re straightforward about which applications have stronger evidence and which are still developing.

What to Discuss With Your Clinician

What you’re hoping to address, your full medical history (especially cancer history), prior treatments, any imaging you have, and your goals. MSC therapy is rarely a one-and-done solution — it’s typically considered as part of a broader plan.

Approved by the Chambers Clinic Team — last reviewed May 28, 2026.